Paper33765766
Global Protease Activity Profiling Identifies HER2-Driven Proteolysis in Breast Cancer.
Salcedo EC and 5 others. ACS Chem Biol, 2021. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Global Protease Activity Profiling Identifies HER2-Driven Proteolysis in Breast Cancer. Papers, record 33765766. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33765766
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Genes, erbB-2 | Major topic |
| Peptide Hydrolases | Major topic |
| Cell Transformation, Neoplastic | |
| Female | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Proteolysis |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| F32 CA168150 | NCI NIH HHS | United States | F32CA168150 | PubMed and NIH | NIH RePORTER |
| P41 GM103481 | NIGMS NIH HHS | United States | P41GM103481 | PubMed and NIH | NIH RePORTER |
| R21 CA186077 | NCI NIH HHS | United States | R21CA186077 | PubMed and NIH | NIH RePORTER |
| R25 GM056847 | NIGMS NIH HHS | United States | R25GM056847 | PubMed and NIH | NIH RePORTER |
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27900052 | Recent perspectives of breast cancer prognosis and predictive factors. | Oncol Lett | 2016 | https://conductscience.org/library/papers/27900052 | PubMed |
| 2 | 3798106 | Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. | Science | 1987 | https://conductscience.org/library/papers/3798106 | PubMed |
| 3 | 2022183 | A role of the latent TGF-beta 1-binding protein in the assembly and secretion of TGF-beta 1. | EMBO J | 1991 | https://conductscience.org/library/papers/2022183 | PubMed |
| 4 | 8847140 | Invasive phenotype of MCF10A cells overexpressing c-Ha-ras and c-erbB-2 oncogenes. | Int J Cancer | 1995 | https://conductscience.org/library/papers/8847140 | PubMed |
| 5 | 15717996 | Utilizing prognostic and predictive factors in breast cancer. | Curr Treat Options Oncol | 2005 | https://conductscience.org/library/papers/15717996 | PubMed |
| 6 | 26097889 | Targeting Matrix Metalloproteinases in Cancer: Bringing New Life to Old Ideas. | Genes Dis | 2015 | https://conductscience.org/library/papers/26097889 | PubMed |
| 7 | 30237490 | A novel mechanism of plasminogen activation in epithelial and mesenchymal cells. | Sci Rep | 2018 | https://conductscience.org/library/papers/30237490 | PubMed |
| 8 | 28725489 | BMP-2 induces EMT and breast cancer stemness through Rb and CD44. | Cell Death Discov | 2017 | https://conductscience.org/library/papers/28725489 | PubMed |
| 9 | 19876014 | Improved visualization of protein consensus sequences by iceLogo. | Nat Methods | 2009 | https://conductscience.org/library/papers/19876014 | PubMed |
| 10 | 19541862 | Understanding resistance to tamoxifen in hormone receptor-positive breast cancer. | Clin Chem | 2009 | https://conductscience.org/library/papers/19541862 | PubMed |
| 11 | 1582084 | The role of proteolytic enzymes in cancer invasion and metastasis. | Clin Exp Metastasis | 1992 | https://conductscience.org/library/papers/1582084 | PubMed |
| 12 | 25677449 | uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies. | Breast Cancer Res | 2014 | https://conductscience.org/library/papers/25677449 | PubMed |
| 13 | 16955069 | Targeting proteases: successes, failures and future prospects. | Nat Rev Drug Discov | 2006 | https://conductscience.org/library/papers/16955069 | PubMed |
| 14 | 11252954 | Untangling the ErbB signalling network. | Nat Rev Mol Cell Biol | 2001 | https://conductscience.org/library/papers/11252954 | PubMed |
| 15 | 31396557 | Heterocellular gene signatures reveal luminal-A breast cancer heterogeneity and differential therapeutic responses. | NPJ Breast Cancer | 2019 | https://conductscience.org/library/papers/31396557 | PubMed |
| 16 | 2007622 | E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. | J Cell Biol | 1991 | https://conductscience.org/library/papers/2007622 | PubMed |
| 17 | 23023596 | Global identification of peptidase specificity by multiplex substrate profiling. | Nat Methods | 2012 | https://conductscience.org/library/papers/23023596 | PubMed |
| 18 | 11035779 | Coupled two-way clustering analysis of gene microarray data. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/11035779 | PubMed |
| 19 | 20855508 | Fibrillin-1 and -2 differentially modulate endogenous TGF-β and BMP bioavailability during bone formation. | J Cell Biol | 2010 | https://conductscience.org/library/papers/20855508 | PubMed |
| 20 | 10949579 | The plasminogen activation system in tumor growth, invasion, and metastasis. | Cell Mol Life Sci | 2000 | https://conductscience.org/library/papers/10949579 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40964713 | Identifying protease-activated targets and exploring therapeutic applications. | Expert Opin Ther Targets | 2025 | https://conductscience.org/library/papers/40964713 | PubMed |
| 39684836 | Functional Study of PTSMAD4 in the Spermatogenesis of the Swimming Crab Portunus trituberculatus. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39684836 | PubMed |
| 36948708 | Multiplex substrate profiling by mass spectrometry for proteases. | Methods Enzymol | 2023 | https://conductscience.org/library/papers/36948708 | PubMed |
| 35610262 | Maternal serum proteomic profiles of pregnant women with type 1 diabetes. | Sci Rep | 2022 | https://conductscience.org/library/papers/35610262 | PubMed |
| 34729407 | In Vivo Measurement of Granzyme Proteolysis from Activated Immune Cells with PET. | ACS Cent Sci | 2021 | https://conductscience.org/library/papers/34729407 | PubMed |
| 34635581 | A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/34635581 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BMP1 | 649 | PubTator's text mining | https://conductscience.org/library/genes/649 | NCBI Gene |
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33765766
GET https://conductscience.org/api/papers/v1/33765766/references?page=2